Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 23;14(7):1619.
doi: 10.3390/cancers14071619.

Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications

Affiliations
Review

Targeted Dual-Modal PET/SPECT-NIR Imaging: From Building Blocks and Construction Strategies to Applications

Syed Muhammad Usama et al. Cancers (Basel). .

Abstract

Molecular imaging is an emerging non-invasive method to qualitatively and quantitively visualize and characterize biological processes. Among the imaging modalities, PET/SPECT and near-infrared (NIR) imaging provide synergistic properties that result in deep tissue penetration and up to cell-level resolution. Dual-modal PET/SPECT-NIR agents are commonly combined with a targeting ligand (e.g., antibody or small molecule) to engage biomolecules overexpressed in cancer, thereby enabling selective multimodal visualization of primary and metastatic tumors. The use of such agents for (i) preoperative patient selection and surgical planning and (ii) intraoperative FGS could improve surgical workflow and patient outcomes. However, the development of targeted dual-modal agents is a chemical challenge and a topic of ongoing research. In this review, we define key design considerations of targeted dual-modal imaging from a topological perspective, list targeted dual-modal probes disclosed in the last decade, review recent progress in the field of NIR fluorescent probe development, and highlight future directions in this rapidly developing field.

Keywords: PET/SPECT imaging; dual-modal imaging; fluorescence-guided surgery; heptamethine.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): a patent describing these probes has been submitted.

Figures

Figure 1
Figure 1
(a) General schematic of dual-modal imaging. (b) SPECT-CT and fluorescence imaging of ccRCC using 111In-DOTA-girentuximab-IR-800CW (girentuximab mAb targets carbonic anhydrase IX, CA-IX) [19]. (c) CT, PET-CT, and FGS using 68Ga-NOTA-BBN-IR-800CW (BBN targets GRPR) [20]. Images used according to permissions from respective journals.
Figure 2
Figure 2
Classification of targeted-bifunctional (chelator/radionuclide and fluorophore) probes into four generic classes based on connectivity logic: class I—bifunctional fluorophores, class II—bifunctional chelators, class III—bifunctional ligands, and class IV—trifunctional linker connecting chelators, fluorophores, and targeting ligands.
Figure 3
Figure 3
Overview of recent developments of fluorophores with absorbance/emission maxima in the (a) near-infrared and (b) short-wavelength IR regions. Blue, red, and green colors indicate cationic, anionic, and conjugable functional groups, respectively.
Figure 4
Figure 4
(a) FRET-quenched bifunctional probe targeting MMP-14. (b) Fluorogenic heptamethine cyanine based on self-immolative linker chemistry. (c) PSMA-targeted probe containing IR700-DX and 111In-labeled DOTA.

References

    1. James M.L., Gambhir S.S. A molecular imaging primer: Modalities, imaging agents, and applications. Physiol. Rev. 2012;92:897–965. doi: 10.1152/physrev.00049.2010. - DOI - PubMed
    1. Vaz S.C., Oliveira F., Herrmann K., Veit-Haibach P. Nuclear medicine and molecular imaging advances in the 21st century. Br. J. Radiol. 2020;93:20200095. doi: 10.1259/bjr.20200095. - DOI - PMC - PubMed
    1. Ikoma N. ASO Author Reflections: Fluorescent-Image Guidance in Surgical Oncology. Ann. Surg. Oncol. 2020;27:5323–5324. doi: 10.1245/s10434-020-08551-1. - DOI - PubMed
    1. Hernandez Vargas S., Lin C., Tran Cao H.S., Ikoma N., AghaAmiri S., Ghosh S.C., Uselmann A.J., Azhdarinia A. Receptor-Targeted Fluorescence-Guided Surgery With Low Molecular Weight Agents. Front. Oncol. 2021;11:674083. doi: 10.3389/fonc.2021.674083. - DOI - PMC - PubMed
    1. van Dam G.M., Themelis G., Crane L.M., Harlaar N.J., Pleijhuis R.G., Kelder W., Sarantopoulos A., de Jong J.S., Arts H.J., van der Zee A.G., et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: First in-human results. Nat. Med. 2011;17:1315–1319. doi: 10.1038/nm.2472. - DOI - PubMed

LinkOut - more resources